(S (NP (NP (NP (NNP Parkinson) (POS 's)) (NN disease)) (-LRB- -LRB-) (NP (NN PD)) (-RRB- -RRB-)) (VP (VBZ is) (NP (NP (DT a) (JJ common) (JJ neurological) (NN disorder)) (VP (VBN characterized) (PP (IN by) (NP (NN gait) (NN impairment)))))) (. .))
(S (S (NP (NN PD)) (VP (VBZ has) (NP (DT no) (NN cure)))) (, ,) (CC and) (S (NP (NP (DT an) (NN impediment)) (PP (IN to) (S (VP (VBG developing) (NP (DT a) (NN treatment)))))) (VP (VBZ is) (NP (NP (DT the) (NN lack)) (PP (IN of) (NP (DT any) (JJ accepted) (NN method) (S (VP (TO to) (VP (VB predict) (NP (NN disease) (NN progression) (NN rate)))))))))) (. .))
(S (NP (NP (DT The) (JJ primary) (NN aim)) (PP (IN of) (NP (DT this) (NN study)))) (VP (VBD was) (S (VP (TO to) (VP (VB develop) (NP (DT a) (NN model)) (S (VP (VBG using) (NP (NP (JJ clinical) (NNS measures)) (CC and) (NP (NP (JJ biomechanical) (NNS measures)) (PP (IN of) (NP (NP (NN gait)) (CC and) (NP (JJ postural) (NN stability)))))) (S (VP (TO to) (VP (VB predict) (NP (NP (DT an) (NN individual) (POS 's)) (NN PD) (NN progression)) (PP (IN over) (NP (CD two) (NNS years)))))))))))) (. .))
(S (NP (NP (NNS Data)) (PP (IN from) (NP (CD 160) (NN PD) (NNS subjects)))) (VP (VBD were) (VP (VBN utilized))) (. .))
(S (NP (NP (NML (NN Machine) (NN learning)) (NNS models)) (, ,) (UCP (PP (VBG including) (NP (NN XGBoost))) (CC and) (S (VP (VB Feed) (NP (NNP Forward) (JJ Neural) (NNS Networks)))))) (, ,) (VP (VBD were) (VP (VBN developed) (S (VP (VBG using) (NP (NP (JJ extensive) (NN model) (NN optimization)) (CC and) (NP (NN cross-validation))))))) (. .))
(S (NP (DT The) (ADJP (JJS highest) (VBG performing)) (NN model)) (VP (VBD was) (NP (NP (DT a) (JJ neural) (NN network)) (SBAR (WHNP (WDT that)) (S (VP (VP (VBD used) (NP (NP (DT a) (NN group)) (PP (IN of) (NP (JJ clinical) (NNS measures))))) (, ,) (VP (VBD achieved) (NP (NP (DT a) (NN PPV)) (PP (IN of) (NP (CD 71) (NN %)))) (PP (IN in) (S (VP (VBG identifying) (NP (JJ fast) (NNS progressors)))))) (, ,) (CC and) (VP (VBD explained) (NP (NP (NP (DT a) (JJ large) (NN portion)) (-LRB- -LRB-) (NP (CD 37) (NN %)) (-RRB- -RRB-)) (PP (IN of) (NP (NP (DT the) (NN variance)) (PP (IN in) (NP (NP (DT an) (NN individual) (POS 's)) (NN progression) (NN rate)))))) (PP (IN on) (NP (ADJP (VBN held) (HYPH -) (RP out)) (NN test) (NNS data))))))))) (. .))
(S (NP (DT This)) (VP (VBZ demonstrates) (NP (DT the) (JJ potential)) (S (VP (TO to) (VP (VP (VB predict) (NP (NML (JJ individual) (NN PD)) (NN progression) (NN rate))) (CC and) (VP (VB enrich) (NP (NNS trials)) (PP (IN by) (S (VP (VBG analyzing) (NP (ADJP (JJ clinical) (CC and) (JJ biomechanical)) (NNS measures)) (PP (IN with) (NP (NN machine) (NN learning))))))))))) (. .))
